ASCENT Intervention for Brain Tumor Patients
{ "ASCENT Intervention for Brain Tumor Patients", "This study is testing a psychosocial intervention called ASCENT (ACT-based Supportive intervention for patients with CENTral nervous system tumors) for people recently diagnosed with a malignant brain tumor. The ASCENT intervention involves six one-on-one coaching sessions to help you cope with your illness. Researchers want to see if this intervention is practical to carry out and helpful for patients. You would participate in these sessions and complete short surveys over 12 weeks. Some participants may also be asked for feedback through interviews. This study is currently recruiting participants to refine the intervention before a larger study begins.", "design": "This study is currently recruiting 15 stakeholders and 10 open pilot participants to gather feedback. After this, it will be a pilot randomized controlled trial with 100 participants.", "commitments": "You would participate in six one-on-one coaching sessions and complete short surveys at four different times. Some participants will also be asked to share feedback via interviews.", "compensation": "Not stated in the trial record.", "follow_up": "The primary goals of the study are measured up to 12 weeks after starting the intervention.", }
- Study design
- Not specified.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
ASCENT Intervention for Brain Tumor Patients
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Deborah A Forst, MD · PRINCIPAL_INVESTIGATOR · Massachusetts General Hospital
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Feasibility of the Intervention: Percentage of Eligible Patients Who Enroll and Participate in the InterventionUp to 12 weeks
The investigators will assess feasibility by examining the percentage of eligible patients who agree to enroll in the study and the percentage of enrolled patients who participate in all six intervention sessions. The intervention will be deemed feasible if at least 60% of eligible patients enroll in the study and if at least 70% of enrolled patients complete at least half of the sessions.
- Acceptability of the Intervention: Percentage of Participants who Have High Satisfaction with the Intervention12 weeks
The investigators will assess acceptability via examining the distribution of patient scores for the 8-item Client Satisfaction Questionnaire (CSQ-8). CSQ-8 scores range from 8 to 32, with higher scores indicating higher satisfaction. The intervention will be deemed acceptable if at least 70% of patients score at least 24 points on the CSQ-8.